Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: A case report and literature review

  • Ping Tao Tseng
  • , Yu Lee
  • , Ya En Lin
  • , Pao Yen Lin*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

25 Scopus citations

Abstract

Prolongation of the corrected QT interval (QTc) on the electrocardiography is an important clinical condition because it increases the risk of torsade de pointes, a medical emergency that can cause sudden cardiac death. QTc prolongation can be induced by many drugs, including antipsychotics and tricyclic antidepressants (TCAs). Compared with TCAs, use of selective serotonin reuptake inhibitors (SSRIs) was less likely to cause severe cardiac adverse effects. Escitalopram, one of the SSRIs, has shown significant antidepressant efficacy and well tolerability. Here, we present one female patient showing QTc prolongation induced by low-dose (5 mg/day) treatment of escitalopram for 2 days. The QTc returned to normal soon after discontinuation of escitalopram. Clinicians should be cautious about cardiac effects when using a SSRI, even in a low dose.

Original languageEnglish
Pages (from-to)210.e13-210.e15
JournalGeneral Hospital Psychiatry
Volume34
Issue number2
DOIs
StatePublished - 03 2012

Keywords

  • Electrocardiography
  • Escitalopram
  • QTc prolongation

Fingerprint

Dive into the research topics of 'Low-dose escitalopram for 2 days associated with corrected QT interval prolongation in a middle-aged woman: A case report and literature review'. Together they form a unique fingerprint.

Cite this